Alx Oncology Holdings Inc (ALXO)

May 02, 2026

Favourable Signals For ALX Oncology Holdings: Numerous Insiders Acquired Stock - Yahoo Finance

May 02, 2026

Apr 30, 2026

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026 - Yahoo Finance

Apr 30, 2026

Apr 29, 2026

BioAffinity stock surges 113.8% in 3 months: What's driving the rally? - MSN

Apr 29, 2026

Apr 28, 2026

ALX Oncology (ALXO) amendment shows Millennium affiliates report 1.99M shares - Stock Titan

Apr 28, 2026

Apr 24, 2026

ALXO Stock Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill

Apr 24, 2026

Apr 23, 2026

ALXO (ALX Oncology Holdings Inc.) reports narrow Q4 2025 EPS miss sending shares 0.6% lower on mild investor disappointment.Sector Perform - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 23, 2026

Buy or Sell? | ALX Oncology Holdings Inc. posts 0.1% EPS miss, no revenue dataRevision Downgrade - Xã Thanh Hà

Apr 23, 2026

Apr 22, 2026

ALX Oncology (ALXO) Stock Analysis: Buy or Sell? | ALX Oncology Holdings Inc. posts 0.1% EPS miss, no revenue dataMoat - Cổng thông tin điện tử Tỉnh Sơn La

Apr 22, 2026

Apr 21, 2026

ALXO Financials: Income Statement, Balance Sheet & Cash Flow | Alx Oncology Holdings Inc - Stock Titan

Apr 21, 2026

Apr 20, 2026

ALX Oncology | ARS: Annual Report to Security Holders - Moomoo

Apr 20, 2026

Apr 20, 2026

[ARS] ALX ONCOLOGY HOLDINGS INC SEC Filing - Stock Titan

Apr 20, 2026

Apr 20, 2026

[DEF 14A] ALX ONCOLOGY HOLDINGS INC Definitive Proxy Statement - Stock Titan

Apr 20, 2026

Apr 18, 2026

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - Sahm

Apr 18, 2026

Apr 18, 2026

ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Apr 18, 2026

Apr 18, 2026

ALXO PE Ratio & Valuation, Is ALXO Overvalued - Intellectia AI

Apr 18, 2026

Apr 17, 2026

Alx Oncology reports inducement grant as permitted by the Nasdaq Listing Rules - marketscreener.com

Apr 17, 2026

Apr 17, 2026

ALX Oncology (NASDAQ: ALXO) awards 800,000 options to chief officer - Stock Titan

Apr 17, 2026

Apr 17, 2026

ALX Oncology (ALXO) awards CMO 100,000 stock options at $1.68 - Stock Titan

Apr 17, 2026

Apr 17, 2026

Jeff Knight named reporting insider at ALX Oncology (NASDAQ: ALXO) with no trades - Stock Titan

Apr 17, 2026

Apr 16, 2026

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - The Globe and Mail

Apr 16, 2026

Apr 13, 2026

ALX Oncology Holdings Inc. Appoints Jeff Knight As Chief Development And Operating Officer, Effective April 13, 2026 - marketscreener.com

Apr 13, 2026

Apr 13, 2026

Stock Market Recap: Is ALX Oncology Holdings Inc a stock for growth or value investorsTrade Risk Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

ALX Oncology names Jeff Knight as chief development officer By Investing.com - Investing.com Australia

Apr 13, 2026

Apr 13, 2026

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer to Advance Cancer Therapy Pipeline 1 - Minichart

Apr 13, 2026

Apr 13, 2026

ALX Oncology names Jeff Knight as chief development officer - Investing.com

Apr 13, 2026

Apr 13, 2026

ALX Oncology Appoints Jeff Knight to Lead Development - TipRanks

Apr 13, 2026

Apr 13, 2026

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer - Bitget

Apr 13, 2026

Apr 13, 2026

Jeff Knight joins ALX Oncology (NASDAQ: ALXO) as development chief - Stock Titan

Apr 13, 2026

Apr 13, 2026

ALX brings in 30-year biotech veteran ahead of key cancer milestones - Stock Titan

Apr 13, 2026

Apr 13, 2026

Press Release: ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer - Moomoo

Apr 13, 2026

Apr 13, 2026

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update - MarketBeat

Apr 13, 2026

Apr 12, 2026

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 12, 2026

Apr 11, 2026

Profit Recap: What are the risks of holding ALX Oncology Holdings Inc2026 Final Week & Trade Opportunity Analysis - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Retail Trends: Can ALX Oncology Holdings Inc reach all time highs this year2026 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

LRMR stock on the move: What sparked the 55% jump in the past month? - MSN

Apr 09, 2026

Apr 08, 2026

Geopolitics Watch: Is ALX Oncology Holdings Inc attractive at current valuation2026 Price Targets & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Block Trades: Will ALX Oncology Holdings Inc benefit from government policyPortfolio Risk Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

What is driving long-term growth of ALX Oncology (ALXO) Stock | Price at $1.83, Down 6.63%Crowd Risk Alerts - Xã Thanh Hà

Apr 08, 2026

Apr 07, 2026

ALXO Stock Price, Quote & Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill

Apr 07, 2026

Apr 04, 2026

ALXO Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 01, 2026

RLMD Stock Surges 42% in a Week: Here's What You Should Know - Eastern Progress

Apr 01, 2026

Mar 31, 2026

Certain Common Stock of ALX Oncology Holdings Inc. are subject to a Lock-Up Agreement Ending on 1-APR-2026. - marketscreener.com

Mar 31, 2026